Treatment with cetuximab (Erbitux) was less
effective for patients with advanced colorectal cancer...
|
Robert Tjian, a distinguished UC Berkley biochemist
and gene researcher, has been named president...
|
Friday, Federal
Drug Administration officials announced the launch of an investigation on...
|
Johnson & Johnson introduced an experimental drug called ustekinumab that is said to show...
|
A recent short term trial reached the conclusion that an experimental drug called Ustekinumab,...
|
Amgen’s experimental bone drug, called
denosumab, was found to reduce the risk of spinal fractures...
|
Johnson & Johnson unveiled Thursday results of a
late-stage trial that showed its psoriasis...
|
Biotechnology company Amgen Inc. will release
the results of the study on its osteoporosis drug...
|
The Food and Drug Administration ordered
stronger warnings about the risk of potentially deadly...
|
Men who present high levels of calcium in their bloodstream are more likely to be exposed to an...
|
New U.S.-Canadian research shows that direct-to-consumer
(DTC) advertising’s effects on drug sales...
|
The Food and Drug Administration approved on Friday Nplate,
a drug produced by Amgen Inc. which...
|
Following the recommendation of its expert panel back in March, the Food and Drug Administration...
|
Nplate, Amgen’s drug destined for patients suffering from a rare blood disorder called chronic...
|
US FDA
ordered Amgen Inc on Wednesday to change the labels for Aranesp and similar
anemia drugs...
|
A new study has found that a combination of two drugs,
Enbrel and methotrexate, halts progression...
|
Biotech drug manufacturer Amgen Inc. announced on Monday
that its experimental drug denosumab...
|
A study published in the July 3 issue of the New England
Journal of Medicine reveals that Amgen...
|
A Food and Drug Administration advisory panel said Wednesday that wider use of Amgen Inc’s...
|
A FDA panel recommended that the psoriasis drug Enbrel should
be approved for the treatment of the...
|
Recombinant-DNA drug Enbrel, made by Amgen, is apparently worrying the U.S. Food and Drug...
|
The U.S. Food and Drug Administration on Wednesday announced
a safety review of several drugs...
|
The Food and Drug Administration will begin studies to find out if there is any connection between...
|
Amgen Inc and Wyeth’s Enbrel arthritis and psoriasis drug
will carry a new “black box” warning...
|
A Food and Drug Administration panel voted unanimously today that Amgen Inc.’ Nplate drug, used to...
|
A Food and Drug Administration panel will vote Wednesday on
whether Amgen Inc.’ NPLATE drug to...
|
A new study revealed that treating cancer patients with
anemia drug increases their risk of blood...
|
A new study published in the February 27, 2008 issue of the Journal of the American Medical...
|
Amgen, a Thousand
Oaks, Calif., biotechnology
company and Wyeth Pharmaceuticals, a division of...
|
The Food and Drug Administration has stated that it is
reviewing new data that provide further...
|
